Neuralstem raises $20 million in funding from China-based pharmaceutical company – Washington Business Journal
Chester News |
Neuralstem raises $20 million in funding from China-based pharmaceutical company
Washington Business Journal Germantown-based stem cell therapy company Neuralstem Inc. announced this week it had closed a $20 million investment. China-based investor Tianjin Pharmaceutical Group International Holdings Co. Ltd. will receive 28.5 million shares of common stock … Parrent Action Alert: A Reversal for Neuralstem, Inc. Is Not Near. The Formed Bearish Multiple Bottom |
